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Abstract
A report on the Genome Informatics conference, held
at the Wellcome Genome Campus Conference Centre,
Hinxton, United Kingdom, 19–22 September 2016.
We report a sampling of the advances in computational
genomics presented at the most recent Genome Informat-
ics conference. As in Genome Informatics 2014 [1], speak-
ers presented research on personal andmedical genomics,
transcriptomics, epigenomics, and metagenomics, new
sequencing techniques, and new computational algo-
rithms to crunch ever-larger genomic datasets. Two
changes were notable. First, there was a marked increase
in the number of projects involving single-cell analy-
ses, especially single-cell RNA-seq (scRNA-seq). Second,
while participants continued the practice of present-
ing unpublished results, a large number of the presen-
ters had previously posted preprints on their work on
bioRxiv (http://www.bioRxiv.org) or elsewhere. Although
earlier in 2016, Berg et al. [2] wrote that “preprints are cur-
rently used minimally in biology”, this conference showed
that in genome informatics, at least, they are already used
quite widely.
Personal andmedical genomics
Several talks covered systems and new technologies that
clinicians, patients, and researchers can use to understand
human genomic variation. Jessica Chong (University of
Washington, USA) described MyGene2 (http://mygene2.
org), a website that allows families to share their de-
identified personal data and find other families with simi-
lar traits. Jennifer Harrow (Illumina, UK) discussed using
BaseSpace (https://basespace.illumina.com/) for the anal-
ysis of clinical sequencing data. Deanna Church (10x
Genomics, USA) presented Linked-Reads, a technology
that makes it easier to find variants in less accessible
genomic regions such as the HLA locus. Several presen-
ters showed newmethods to identify the functional effects
*Correspondence: michael.hoffman@utoronto.ca
1Princess Margaret Cancer Centre, Toronto, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, Canada
Full list of author information is available at the end of the article
of sequence variants. Konrad Karczewski (Massachusetts
General Hospital, USA) presented the Loss Of Func-
tion Transcript Effect Estimator (LOFTEE, https://github.
com/konradjk/loftee). LOFTEE uses a support vector
machine to identify sequence variants that significantly
disrupt a gene and potentially affect biological processes.
Martin Kircher (University of Washington, USA) dis-
cussed a massively parallel reporter assay (MPRA) that
uses a lentivirus for genomic integration, called lentiM-
PRA [3]. He used lentiMPRA to predict enhancer activity,
and to more generally measure the functional effect of
non-coding variants. William McLaren (European Bioin-
formatics Institute, UK) presented Haplosaurus, a variant
effect predictor that uses haplotype-phased data (https://
github.com/willmclaren/ensembl-vep).
Two presenters discussed genome informatics
approaches to the analysis of cancer immunotherapy
response. Meromit Singer (Broad Institute, USA) per-
formed single-cell RNA profiling in dysfunctional CD8+
T cells. She identified metallothioneins as drivers of T
cell dysfunction and revealed novel sub-populations of
dysfunctional T cells [4]. Christopher Miller (Wash-
ington University, St Louis, USA) tracked the
response to cancer immunotherapy in the genome of
patients [5].
In a keynote lecture, Elaine Mardis (Washington
University, St Louis, USA), described computational tools
and databases created to collect and process cancer-
specific mutation datasets. A substantive increase in
the amount of clinical sequencing performed as part of
cancer diagnosis and treatment necessitated the devel-
opment of these tools. She emphasized the shift in
categorization of cancers—previously oncologists clas-
sified cancers by tissue, but increasingly they classify
cancers by which genes are mutated. Mardis suggested
that we should instead describe cancers by the affected
metabolic and regulatory pathways, which can provide
insight even for previously unseen disruption. This dis-
ruption can be genetic mutations, but it can also man-
ifest as other changes to cellular state, which must be
measured with other techniques, such as RNA-seq. The
tools Mardis described help interpret the mutations iden-
tified by sequencing. These include the Database of
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Curated Mutations (DoCM). She also described Personal-
ized Variant Antigens by Cancer Sequencing (pVAC-seq),
a tool for identifying tumor neoantigens from DNA-seq
and RNA-seq data. She also described Clinical Inter-
pretations of Variants in Cancer (CIViC), a platform
for crowd-sourcing data on clinical consequences of
genomic variants. CIViC has 1565 evidence items describ-
ing the interpretation of genetic variants, and Mardis
announced a forthcoming Variant Curation Hackathon to
identify more.
Variant discovery and genome assembly
Several speakers presented tools and methods about anal-
ysis of genome assemblies and exploration of sequence
variants. Jared Simpson (Ontario Institute for Cancer
Research, Canada) started the second session with an
overview of base calling for Oxford Nanopore sequenc-
ing data and his group’s contribution to this field,
Nanocall (http://github.com/mateidavid/nanocall). Simp-
son also discussed Nanopolish, which can detect 5-
methylcytosine from Oxford Nanopore sequencing data
directly, without bisulfite conversion. KerstinHowe (Well-
come Trust Sanger Institute, UK) presented her work
with the Genome Reference Consortium on produc-
ing high quality assemblies for different strains of
mouse and zebrafish. Ideally, future work will integrate
graph assemblies. Frank Nothaft (University of California,
Berkeley, USA) described ADAM (https://github.com/
bigdatagenomics/adam), a library for distributed com-
puting on genomics data, and Toil, a workflow man-
agement system. These systems are about 3.5 times
faster than standard Genome Analysis Toolkit (GATK)
pipelines.
Some presenters discussed genome assembly tools
and datasets which might be utilized by the wider
community. Andrew Farrell (University of Utah, USA)
introduced RUFUS (https://github.com/jandrewrfarrell/
RUFUS), a method for efficiently detecting de novo muta-
tion using k-mer counting instead of reference-guided
alignment. Alicia Oshlack (Murdoch Childrens Research
Institute, Australia) presented the SuperTranscript model
for enhancing transcriptome visualization (https://github.
com/Oshlack/Lace/wiki). Jouni Sirén (Wellcome Trust
Sanger Institute, UK) presented a method to index pop-
ulation variation graphs using FM-index [6]. His new
package, GCSA2 (https://github.com/jltsiren/gcsa2), pro-
vides a toolkit to work with variation graphs. Birte
Kehr (deCODE Genetics, Iceland) introduced a whole-
genome sequencing dataset of approximately 15,000 Ice-
landers comprising approximately 4000 variants from
non-repetitive sequences not in the reference assembly
[7]. Giuseppe Narzisi (New York Genome Center, USA)
presented Lancet, software to find somatic variants using
localized colored De Bruijn graphs.
In a keynote lecture, Richard Durbin (Wellcome
Trust Sanger Institute, UK) discussed genome reference
assemblies and the pitfalls of using a single flat refer-
ence sequence. Genomicists use the reference genome
for mapping sequencing reads, as a coordinate system
for reporting and annotation, and as a framework for
describing known variation. While the reference genome
makes many analyses simpler, it biases these analyses
towards what is previously seen. Durbin briefly discussed
the advantages of the newest human reference assem-
bly, GRCh38, which fixes many previous problems and
includes alternate loci to capture complex genetic vari-
ation. But to more effectively work with this variation,
Durbin said we need to switch from a flat reference to
a “pan-genome” graph that includes much known vari-
ation [8]. To do this, we will need a new ecosystem of
graph genome file formats and analysis software. Durbin
discussed the work of the Global Alliance for Genomics
and Health to evaluate proposed systems for working with
graph genomes.
Epigenomics and the non-coding genome
Speakers described new methods for epigenomic data,
such as DNase-seq (deoxyribonuclease sequencing),
ChIP-seq (chromatin immunoprecipitation sequenc-
ing), and RNA-seq data. Christopher Probert (Stanford
University, USA) presented DeepNuc, a deep learning
technique able to determine nucleosome positioning
from paired-end ATAC-seq datasets. Michael Hoffman
(Princess Margaret Cancer Centre, Canada) described
a method to analyze ChIP-seq and RNA-seq datasets
and classify transcription factor binding sites into
four binding variability categories: static, expression-
independent, expression-sensitive, and low [9]. Anshul
Kundaje (Stanford University, USA) described a deep
learning approach that integrates epigenomic datasets
(such as DNase-seq or ATAC-seq) to predict transcrip-
tion factor binding sites across diverse cell types. Kundaje
also presented a new way to interpret the learned model
(https://github.com/kundajelab/deeplift).
Several presenters described the analysis of tran-
scription factor binding sites and enhancers. Katherine
Pollard (University of California, San Francisco,
USA) described methods for the analysis and pre-
diction of promoter–enhancer interactions [10]. Vera
Kaiser (University of Edinburgh, UK) characterized
mutational profiles of transcription factor binding sites.
Sarah Rennie (University of Copenhagen, Denmark)
presented a Bayesian model across Functional Annota-
tion of the Mammalian Genome (FANTOM) samples
to compute simultaneous random walks across sets of
potential transcription initiation events. Rani Elkon (Tel
Aviv University, Israel) performed a large-scale search for
enhancer regions in the human genome [11].
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Data curation and visualization
Speakers described several tools to help genome infor-
maticists to visualize data. Kim Pruitt (National Library
of Medicine, USA) described Sequence Viewer to display
sequence and annotation data, and Tree Viewer to view
phylogenetic tree data. She also presents Genome Work-
bench (https://www.ncbi.nlm.nih.gov/tools/gbench/), a
tool suite that runs both Sequence Viewer and Tree
Viewer in local environments. David Powell (Monash
University, Australia) presented Degust (http://victorian-
bioinformatics-consortium.github.io/degust/), a web tool
to analyze gene expression datasets. Degust can produce
a principal component analysis visualization, clustering
aspects of a user’s dataset. Jonathan Manning (University
of Edinburgh) presented Shinyngs (https://github.com/
pinin4fjords/shinyngs), an R package for generating plots
from RNA-seq data. Birgit Meldal (European Bioin-
formatics Institute, UK) described the Complex Portal
(https://www.ebi.ac.uk/intact/complex/), a tool for ana-
lyzing and visualizing protein complexes.
A few speakers presented on curating data from the
literature. Alex Bateman (European Bioinformatics Insti-
tute, UK) analyzed the feasibility of curating data on
biomolecules from the literature. He determined that
despite a vast increase in the amount of biomedical lit-
erature, most does not need to be analyzed by curators.
Benjamin Ainscough (Washington University, St Louis,
USA) described DoCM (http://docm.genome.wustl.edu/),
a database of known mutations in cancer. DoCM contains
approximately 1000 mutations in 132 cell lines.
Ismail Moghul (Queen Mary University of London,
UK) presented GeneValidator, which identifies potential
problems in gene prediction, by comparing predicted
genes with gene annotations from other resources.
Ryan Layer (University of Utah, USA) described
GIGGLE (https://github.com/ryanlayer/giggle), a fast
genomics data search engine.
Transcriptomics, alternative splicing, and gene
prediction
Speakers discussed several aspects of analyzing tran-
scriptomic datasets. Hagen Tilgner (Weill Cornell
Medicine, USA) described the use of long read tech-
nology to discover novel splice isoforms and long
non-coding RNAs (lncRNAs) in the human transcrip-
tome. Simon Hardwick (Garvan Institute of Medical
Research, Australia) presented a set of spike-in standards
for RNA-seq, called Sequins (http://www.sequin.xyz/).
These standards act as a ground truth to measure the
accuracy and precision of transcriptome sequencing.
Pall Melsted (University of Iceland, Iceland) presented
Pizzly, a new tool to detect the gene fusions that often
occur in cancer from transcriptome data, approximately
100 times faster than established methods. Annalaura
Vacca (University of Edinburgh, UK) presented a
meta-analysis of FANTOM5 cap analysis gene expres-
sion (CAGE) time-course expression datasets. Using
these data, she identified known immediate early genes
and candidate novel immediate early genes.
Several speakers discussed new methods for single-
cell RNA expression, including scRNA-seq. Davis
McCarthy (European Bioinformatics Institute, UK) pre-
sented Scater [12], an R package for scRNA-seq datasets.
McCarthy stressed the need for carefully designed
studies, rigorous quality control, and appropriate han-
dling of batch effects. Alexandra-Chloe Villani (Broad
Institute, USA) analyzed chromosomal copy number
aberrations and gene expression data on hundreds of
individual peripheral blood mononuclear cells. She
used Seurat (http://satijalab.org/seurat/) for spatial
reconstruction, identifying six subtypes of dendritic
cells and respective markers. Johannes Köster (Cen-
trum Wiskunde & Informatica, the Netherlands) a new
Bayesian model (http://zhuang.harvard.edu/merfish/)
for reducing systematic bias in multiplexed error-robust
fluorescence in situ hybridization (MERFISH) data. Shan-
non McCurdy (University of California, Berkeley, USA)
applied a column subset selection method for dimen-
sionality reduction to scRNA-seq datasets. This method
selects a subset of columns from a gene expressionmatrix,
preserving properties such as sparsity and interpretability.
Comparative, evolutionary, andmetagenomics
Some projects on analysis of metagenomics datasets
were presented. Owen White (University of Maryland,
USA) presented an update on the Human Microbiome
project, which ties together metagenomics data with
phenotype data on host individuals. Curtis Huttenhower
(Harvard University) described using HUMAnN2
(http://huttenhower.sph.harvard.edu/humann2) to pro-
cess metagenomics and metatranscriptome data from the
Human Microbiome Project (http://hmpdacc.org/).
A few speakers discussed comparative genomics and
evolutionary approaches. James Havrilla (University of
Utah, USA) presented a statistical model to identify
constraint in different domains within a protein. Sonja
Dunemann (University of Calgary, Canada) described the
caution necessary before claiming horizontal gene trans-
fer. David Curran (University of Calgary, Canada) pre-
sented work on Figmop [13], a profile hidden Markov
model that identifies orthologs not identifiable using the
popular Basic Local Alignment Search Tool (BLAST)
method.
Several speakers described analyses of genetic traits
in population-level datasets. Sriram Sankararaman
(University of California, Los Angeles, USA) presented
an analysis of human admixture with Neanderthal and
Denisovan populations [14]. AliciaMartin (Massachusetts
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General Hospital) presented work using the Sequenc-
ing Initiative Suomi (SISu, http://sisuproject.fi/) data
to understand recent population history and migration
in Finnish populations. Moran Gershoni (Weizmann
Institute of Science, Israel) described sex differentially
expressed genes from common tissues from Genotype-
Tissue Expression (GTEx) [15] data. He identified 244
X-linked sex differentially expressed genes, 16 of which
are in multiple tissues.
Conclusion
The presentations described above were a major attrac-
tion of this conference. As in most conferences, of course,
the ability to interact with conference attendees provided
another major benefit. Increasingly, these benefits accrue
not just to the hundreds of in-person attendees at the
conference but to thousands of scientists elsewhere. The
meeting had an “open by default” policy that encour-
aged wide discussion of presentations on Twitter and
elsewhere. By following the meeting via Twitter, reading
preprints on bioRxiv, examining software on GitHub and
Bitbucket, and viewing slide decks posted on the internet,
many engaged with the advances presented in Hinxton
without leaving their home. Even those at the meeting
enjoyed an enhanced ability to discuss newwork both dur-
ing and after talks. And those who participated in Twitter
found new colleagues to interact and collaborate with long
after the meeting ended.
While one can follow Genome Informatics from thou-
sands of miles away, we cannot deny the importance
of the meeting itself as a locus for bringing together
new research and engaged researchers. Although results
are now immediately available to all, there is no sub-
stitute for attending in person, which is also the only
way to present work at the meeting. And it was the
thematically balanced and high-quality program that
attracted so much discussion in the first place. We hope
that this history of an interesting and excellent scien-
tific program continues and look forward to Genome
Informatics 2017.
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